About this trial
The goal of this observational study is to determine the effectiveness of a specialisation of multisystemic therapy (MST) for adolescents with severe behavioural problems from families with an intellectual disability (ID; MST-ID).
To achieve this goal, a mixed method study design is used. To this end, a quantitative and a qualitatively primary research question are formulated:
* Is MST-ID superior, when compared to standard MST, in reducing rule-breaking behaviour of adolescents (quantitative)? * What are the experiences of adolescents and/or parents receiving MST-ID treatment (qualitative)?
Participants will be asked to complete two screeners (questionnaires delivered as a verbal interview) with a total duration of approximately 30 minutes. Other data will be collected through Routine Outcome Monitoring questionnaires that are part of standard MST procedures. To this end, five 'time points' have been identified: T0 (start of MST\[-ID\] treatment), T1 (end of MST\[-ID\] treatment), T2 (follow-up 6 month after MST\[-ID\] treatment), T3 (follow-up 12 month after MST\[-ID\] treatment), and T4 (follow-up 18 month after MST\[-ID\] treatment). The qualitative method used to gain insight into families' experiences is determined in consultation with the families.
To assess the effectiveness of MST-ID, its treatment outcomes will be compared to standard MST treatment outcomes of families with ID.
Eligibility criteria
Qualifiers
Known or suspected ID of the referred adolescent and/or their parent(s);
Educational level of the referred adolescent and/or highest attained diploma of their parent(s) is indicative of potential ID.
Adolescent must be 10 to 19 years old at the start of treatment;
Adolescent presents with severe behavioural problems in at least two life areas;
Disqualifiers
Adolescent lives independently;
Adolescent presents with severe problematic sexual behaviours, without presenting with other severe behavioural problems;
Adolescent presents suicidal, psychotic, or homicidal requiring specialised treatment (such as a crisis placement in a residential facility);
Adolescent has a severe Autism Spectrum Disorder (level 2-3 according to the Diagnostic and Statistical Manual of Mental Disorders [DSM-V] criteria) or a severe ID (IQ score <50);
Trial design
Treatments tested in this trial
- Multisystemic therapy
- Multisystemic therapy - intellectual disabilities
Treatment groups
Sponsors and collaborators
De Viersprong
Lead sponsor
Stichting tot Steun
Collaborator
Koraal
Collaborator
Prisma
Collaborator
MST-Netherlands/Belgium
Collaborator
Radboud University Medical Center
Collaborator
Pactum
Collaborator